Product Description

Mitant 12.5mg Capsule consists of the active ingredient Sunitinib. It is prescribed for patients with kidney cancer and stomach cancer that has started to spread to other tissues. This medication is preferred for patients who have not responded adequately to other chemotherapy treatments and cancer therapies like Imatinib therapy and cytokine therapy. Side effects include hypertension, rashes, diarrhoea, weakness, bleeding, protein in urine, hypothyroidism, neutropenia etc.

How to use

Take Mitant 12.5mg Capsule as directed by your physician. 

Uses

Treatment of Cancer
Treatment of Kidney Disease/Stones

Side Effects

Serious:

• Painful skin ulcer.
• Skin/soft tissue infections that are rapidly spreading.
• Severe skin rashes.
• Discolouration of hair or skin.
• Higher risk of bleeding.
• Heart problems.
• Altered frequency of urination.

Common:

• Diarrhea, nausea, vomiting and dyspepsia.
• Dryness, thickness or cracking of skin and blisters.
• Extreme Tiredness.
• Bleeding.
• High BP.
• Swelling.

Storage

Store below 30℃